This randomized trial assessed the effects of a 24-month physical activity program on cognitive function, mild cognitive impairment, and dementia compared with a health education program in sedentary adults aged 70 to 89 years.
This randomized trial reports that among older individuals with age-related macular degeneration supplements containing long-chain fatty acids and/or lutein and zeaxanthin had no effect on cognitive function.
This study uses data for pediatric patients from the Get With the Guidelines–Resuscitation registry to report associations between delay in epinephrine and survival and neurological outcome after pediatric in-hospital cardiac arrest.
This cohort study investigates clearance patterns of somatic mutations in acute myeloid leukemia patients given induction chemotherapy, and associations between those patterns and clinical outcomes.
This study used Veterans Health Administration data to investigate the association between misconduct-related separations and homelessness among recently returned active-duty US military service members.
This Viewpoint discusses a framework for improving patient care and public sexual health.
This Viewpoint proposes ways that electronic health records and other “big data” can be integrated with randomized trial designs to leverage the strengths of both for research inferences.
This Viewpoint discusses developing quality metrics in behavioral and general health care to encourage more cost-effective care and improve the status quo.
This Viewpoint discusses the importance of a well-trained and well-prepared health workforce in controlling outbreaks such as Middle East respiratory syndrome.
This commentary describes a report published in JAMA Pediatrics summarizing a National Institutes of Health workshop about primary care clinician involvement in preventing early childhood obesity.
This JAMA Clinical Guidelines Synopsis summarizes the US Preventive Services Task Force’s (2012) and American Urological Association’s (2013) clinical practice guidelines for prostate cancer screening.
A 30-year-old woman with polyarthralgias responsive to celecoxib has an ANA titer of 1:80. How do you interpret this test result?
This Medical News and Perspectives article discusses issues surrounding Right-to-Try laws that allow patients with terminal illness to petition for access to investigational drugs and therapies.
Create a personal account or sign in to: